Onconetix, Inc. (ONCO) earnings

ONCO earnings moved a median of -5.38% by the close. Quarterly and annual ONCO reports and results, each read against the price at its own news timestamp. Back to the ONCO overview →

16 measured ONCO earnings events.

Where these ONCO earnings landedvs 16 measured ONCO earnings reactions
ONCO earningsMiddle 50% · -12.57% to +0.99%Zero: 0.00%Median: -5.38%Median -5.38%-20.00%0+20.00%
Middle 50% of ONCO earnings reactions-12.57% to +0.99%
Median reaction (to close)-5.38%
Measured reactions16
Point-in-time · zero look-ahead

Half of the 16 ONCO earnings events with a measured close landed between -12.57% and +0.99%; 31% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Onconetix, Inc. For: Jun 30SEC filing · Form 10-Q+1.16%-5.66%
Form 10-Q Onconetix, Inc. For: Mar 31SEC filing · Form 10-Q-4.37%-5.10%
Form 10-K Onconetix, Inc. For: Dec 31SEC filing · Form 10-K-1.45%-12.30%
Form 10-Q Onconetix, Inc. For: Jun 30SEC filing · Form 10-Q+0.00%+1.31%
Form 10-Q Onconetix, Inc. For: Mar 31SEC filing · Form 10-Q+3.00%-14.16%
Form 10-K Onconetix, Inc. For: Dec 31SEC filing · Form 10-K-1.45%+0.88%
Form NT 10-K Onconetix, Inc. For: Dec 31SEC filing · Form NT+0.14%+2.30%
Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent FilingPress release-1.86%-11.26%
Form 10-Q Onconetix, Inc. For: Sep 30SEC filing · Form 10-Q-1.49%-13.38%
Form NT 10-Q Onconetix, Inc. For: Sep 30SEC filing · Form NT—-19.30%
Form 10-Q Onconetix, Inc. For: Jun 30SEC filing · Form 10-Q+2.77%-4.69%
Form NT 10-Q Onconetix, Inc. For: Jun 30SEC filing · Form NT+1.75%-1.82%
Form 10-Q Onconetix, Inc. For: Mar 31SEC filing · Form 10-Q-6.31%-14.42%
Form NT 10-Q Onconetix, Inc. For: Mar 31SEC filing · Form NT+9.37%+22.29%
Form 10-K Onconetix, Inc. For: Dec 31SEC filing · Form 10-K+0.07%-9.49%
Form NT 10-K Onconetix, Inc. For: Dec 31SEC filing · Form NT+1.91%+1.97%
That’s how ONCO usually reacts to earnings — get an email when it moves on news →
Keep exploring

More ONCO: analyst actions → · SEC filings → · ONCO overview →